Powers C A
Biochem Biophys Res Commun. 1985 Mar 15;127(2):668-72. doi: 10.1016/s0006-291x(85)80213-8.
The effect of dopamine receptor blockers on glandular kallikrein-like activity in the neurointermediate lobe of the rat pituitary was examined. Male rats were given daily injections of haloperidol (2.5 mg/kg), perphenazine (5 mg/kg) or sulpiride (60 mg/kg) for 7 days. Homogenates of the neurointermediate lobe were prepared. Latent proteases were activated with trypsin and proteolytic activity was measured at 37 degrees C, pH 8.0 using chromogenic peptide substrates. All three dopamine receptor blockers produced about a 100% increase in glandular kallikrein-like activity. The results suggest that glandular kallikrein-like activity in the neurointermediate lobe is under inhibitory control by dopaminergic mechanisms.
研究了多巴胺受体阻滞剂对大鼠垂体神经中间叶中腺激肽释放酶样活性的影响。给雄性大鼠每日注射氟哌啶醇(2.5毫克/千克)、奋乃静(5毫克/千克)或舒必利(60毫克/千克),持续7天。制备神经中间叶的匀浆。用胰蛋白酶激活潜在的蛋白酶,并在37摄氏度、pH值为8.0的条件下使用生色肽底物测量蛋白水解活性。所有三种多巴胺受体阻滞剂均使腺激肽释放酶样活性增加了约100%。结果表明,神经中间叶中的腺激肽释放酶样活性受多巴胺能机制的抑制性控制。